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ColombiaA B S T R A C TObjective: To estimate the economic costs of avoidable mortality (AM)
in Colombia during the period 1998 to 2011, with the human capital
perspective valuing the productivity lost. Methods: The information
of cases of avoidable death was identiﬁed from the Colombian ofﬁcial
general mortality database, and we estimated the potential produc-
tivity years of life lost, assuming a productive life span between 18
years and 57 years and 18 years and 62 years in women and men,
respectively. Two scenarios were built: lower loss with the minimum
wage, and higher loss with the per capita gross domestic product.
Total costs for the period were reported by sex and health event.
Average cost per 1000 people was also estimated. All costs were
adjusted and reported in 2012 US dollars. Results: Sixty-eight percent
of the total AM in Colombia during the period 1998 to 2011 occurredee front matter Copyright & 2015, International S
r Inc.
.1016/j.vhri.2015.08.007
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ndence to: Diana Díaz-Jiménez, Avenida 26 #51-20during or before the productivity age. The total AM costs were
estimated to range between US $80.5 million and US $150.4 million.
Higher costs of AM were incurred in men. Events from the injuries group
caused the higher productivity lost. Conclusions: All the avoidable
deaths in Colombia have a huge economic impact from the productivity
lost perspective, equivalent to between 1.6% and 3.0% of the annual
gross domestic product. The cost analyses in public health are an
additional input for decision making and prioritization of intervention.
Keywords: Colombia, cost and cost-analysis, cost of illness, human
capital approach, mortality.
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Outcomes Research (ISPOR). Published by Elsevier Inc.Introduction
Traditional indicators to measure population health changes
include general and infant mortality and life expectancy. How-
ever, not all deaths occur according to the health expectancy [1].
Premature mortality analysis helps in establishing public health
priorities [2] and in evaluating the economic consequences in
addition to the burden of disease [3].
The concept of avoidable mortality (AM) was initially intro-
duced by Rutstein et al. [4] in the mid-1970s, referring to events
that should not occur in the presence of timely and effective
health care. AM has been considered an indicator of the impact of
public health interventions [5]. AM not only considers the life
expectancy but also includes a judgment over events that
potentially should not occur if there is health promotion and
prevention and proper treatment, and public policies are imple-
mented [6]. Several lists of preventable or amenable causes of
death (CoD) have been published, each of them based on a
different conceptualization of AM [4,7,8].
It is possible to economically value the impact of mortality in
a population through the potential productivity years of life lost
(PPYLL), which evaluate the loss to a society in terms of its
individuals’ productive capacity in relation to the working-agepopulation, considering the wages unearned because of the
premature death [9]. There are two methods to estimate produc-
tivity costs: the human capital approach and the friction costs
method [10–13]. The human capital approach is a traditional
approach for measuring and valuating production that is lost
because of temporary work absences, reduced productivity at
work, and permanent work absence from morbidity or premature
mortality. It assumes no unemployment and captures all lost
productivity due to disease mortality by assuming that individ-
uals who died prematurely would have worked full time until the
end of their working lives [12,14]. In contrast, the friction costs
method captures the lost productivity only until a worker would
likely be replaced by someone [14]. We chose the human capital
approach, which is usually used to evaluate costs of illness
[12,14–16].
Internationally, there are studies that estimate productivity
losses due to premature mortality [14,16–18] but not the cost of
AM. In Colombia, some mortality costs analysis had been carried
out on a subnational scale [9,19,20]; however, there has been no
national analysis estimating the costs of AM. The objective of the
present analysis was to estimate using the human capital
approach the economic costs of avoidable deaths that occurred
in Colombia during the period 1998 to 2011.ociety for Pharmacoeconomics and Outcomes Research (ISPOR).
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A cost-analysis of AM in Colombia was carried out. For the
classiﬁcation of AM, the list of International Classiﬁcation of Disease,
Tenth Revision causes deﬁned in the report of the Colombian
National Health Observatory [6] was used. Concepts and lists of
AM published between 1978 and 2010 were taken into account to
construct the Colombian list [6], including international [7,8] and
Latin American lists [21–23]. To account for the fact that the
effectiveness of (primary and secondary) prevention and treat-
ment of illnesses substantially decreases after a particular age,
deaths only before a speciﬁed age (75 years) [24] were considered
avoidable.
The mortality database for the period 1998 to 2011 was
provided by the Colombian National Institute of Statistics (Depar-
tamento Nacional de Estadísticas). We selected the avoidable death
cases according to the International Classiﬁcation of Disease, Tenth
Revision code for the basic CoD that occurred before the age of
retirement (57 years in women and 62 years in men) [25,26]. For
each avoidable death, the total PPYLLs were estimated. Deaths
that occurred between ages 0 and 17 years were economically
valued as equal to those that occurred in age 18 years.
PPYLLi¼
ar18, if adr18
arad, if ad418
 !
where PPYLLi is potential productivity years of life lost for
individual i, ar is the age of retirement, and ad is the age of death.
The PPYLLs were multiplied by their cost in 2012 US dollars.
Two scenarios were considered: the best-case scenario (lower
loss) with a cost per PPYLL equivalent to the 2012 annual
minimum wage (US $4326.6) [27] and the worst-case scenario
(higher loss) with a cost per PPYLL equivalent to the 2012 per
capita gross domestic product (GDP) (US $8080.3) [28], an indicator
of the average productivity in Colombia.AMW: annual minimum wage
pcGDP: per capita  Gross Domestic Product
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ig. 1 – Low and upper limits for annual salaries according to the
age; pcGDP, per capita gross domestic product.CPPYLLi¼
Xar
ad
CYPLLij
where CPPYLLi is the cost of the total PPYLL for individual i, ad is
the age of death, ar is the age of retirement, and CPPYLLij is the cost
of the PPYLL for individual i in year j.
All costs were reported in 2012 US dollars (US $1 ¼ 1768.23
Colombia pesos [COP]) [29]. The choice of the appropriate dis-
count rate in analyses of productivity costs is controversial and
can be varied [14]. An annual discount rate of 3% was used to
adjust the costs of all periods. This choice was made considering
the fact that in the particular case of economic evaluations of
health technologies in Colombia, most studies use a discount rate
of 3% [30], similar to the rate in the international literature [31].
We conducted a sensitivity analysis using discount rates of 0%
and 5% to include the uncertainty in our estimations. Fig. 1
reports annual salaries applied according to the year of loss. A
half-cycle adjustment was implemented to avoid overestimation
of the economic loss, assuming that all deaths occur on June 30
each year.
Classiﬁcation of events in three main groups—communicable,
maternal, neonatal, and nutritional disorders; noncommunicable
diseases; and injuries—was performed according to the 2010
Global Burden of Disease analysis from the Institute for Health
Metrics and Measurement at the University of Washington [32].
The classiﬁcation also includes 21 groups and 236 individual
events. For the present analysis, injuries of undetermined inten-
tion were included as an additional subgroup in the injuries
group. The results were presented by year, sex, disease, and
department (equivalent to states) of residence. Annual cost
trends were assessed with a linear regression analysis, reporting
the P value of the slope coefﬁcient. All data were managed in
Microsoft Excel 2013 (Microsoft) and Stata 12 (Stata Corporation,
College Station, TX).20
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Table 1 – Costs of avoidable deaths in working age by year and scenario: Colombia (1998–2011).
Year Avoidable death in working age Costs best-case scenario (2012 USD) Costs worst- case scenario (2012 USD)
1998 73,122 7,451,538,176 13,916,321,809
1999 76,604 7,537,820,858 14,077,461,347
2000 79,541 7,665,117,106 14,315,197,058
2001 79,844 7,491,099,668 13,990,205,996
2002 78,853 7,232,923,523 13,508,042,058
2003 72,261 6,255,904,337 11,683,383,302
2004 68,988 5,684,022,222 10,615,349,469
2005 65,020 5,115,898,248 9,554,334,137
2006 64,625 4,888,275,812 9,129,231,840
2007 63,421 4,662,786,187 8,708,112,523
2008 62,203 4,384,487,308 8,188,367,971
2009 63,203 4,402,191,285 8,221,431,515
2010 60,834 4,054,683,048 7,572,433,067
2011 57,594 3,689,704,165 6,890,806,866
Total 966,113 80,516,451,943 150,370,678,958
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Of the total 1,427,535 avoidable deaths in Colombia during the
period 1998 to 2011, 68% (966,113) occurred during or before the
working age. Total PPYLLs were 26,276,842, with an annual
average of 44.03 PPYLLs per 1000 people (Table 1). Total cost of
AM during the period was estimated to be between US $80.5
billion and US $150.4 billion in the best-case and worst-case
scenarios, respectively (Table 1), with a trend of annual decrease
(P o 0.001). The cost in men was estimated to be US $62.5 billion,
with an annual average cost of US $212,240 to US $396,375 per 1000
men. The cost in women was US $18.0 billion (annual average cost
US $59,493–111,108 per 1000 women). The ratio of costs between
men and women for all years was about threefold (Fig. 2).
Ten departments (Colombian states) with the highest AM
costs accounting for 67% of the total costs were Antioquia (US
$14.2 billion to US $26.6 billion), Valle del Cauca (US $10.8 billion
to US $20.1 billion), Bogotá (US $8.8 billion to US $16.5 billion),Fig. 2 – Avoidable mortality costs in working age by year anCundinamarca (US $3.2 billion to US $5.9 billion), Atlántico (US
$3.2 billion to US $5.9 billion), Santander (US $3.1 billion to US $5.8
billion), Norte de Santander (US $3.0 billion to US $5.6 billion),
Cauca (US $2.5 billion to US $4.6 billion), Tolima (US $2.5 billion to
US $4.6 billion), and Bolívar (US $2.5 billion to US $4.6 billion),
whereas Guainía, Vaupés, Archipiélago de San Andrés, Providen-
cia y Santa Catalina, Amazonas, and Vichada reported the lowest
total costs.
The highest average cost per 1000 population for AM was
reported in Caquetá (US $226,036–422,140), Guaviare (US $220,290–
411,408), Arauca (US $211,558–395,101), Meta (US $189,117–353,191),
and Valle del Cauca (US $185,459–346,359), whereas the lowest
average cost was reported in Archipiélago de San Andrés, Provi-
dencia y Santa Catalina, Sucre, Bogotá, Bolívar, and Córdoba.
Costs by Event
By group of CoD, the highest costs corresponded to injuries
(61% of total costs), communicable, maternal, neonatal, andd sex: Colombia (1998–2011) (in thousands of 2012 USD).
Non GBD: Non global burden disease cause 
Fig. 3 – Avoidable mortality costs in the best-case scenario per 22 GBD group causes: Colombia (1998–2011). HIV, HIV/AIDS; TB,
Tuberculosis; Dia, Diarrhea; LRI, Lower respiratory infections; Oth, other common infectious diseases; NTD, Neglected tropical
diseases; Maternal, Maternal disorders; Neonatal, Neonatal disorders; Ntr Def, Nutritional deﬁciencies; CVD, Cardiovascular
and circulatory diseases; Chr Resp, Chronic respiratory diseases; Neuro, Neurological disorders; Mental, Mental and beha-
vioral disorders; Diab, Diabetes; Urog, urogenital; Hem, blood; MSK, Musculosketeal disorders; NCD, Other non-communicable
diseases; Tran Inj, Transport injuries; Unint Inj, Unintentional injuries other than transport injuries; Intent Inj, Self-harm and
interpersonal violence; disaster, forces of nature; Undet int Inj, Injuries with undetermined intent; GBD, global burden
disease.
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(19%). Trends were similar in the three groups (P o 0.001), rising
up to 2002 and decreasing thereafter; however, injuries reported a
peak in 2009. During the ﬁrst 10 years, costs of communicable,
maternal, neonatal, and nutritional disorders exceeded the costs
of noncommunicable diseases, but in the last 4 years the
relationship was reversed. Costs of noncommunicable diseases
showed a 64% decrease during the period, whereas injuries and
communicable, maternal, neonatal, and nutritional disorders
showed decrements of 49% and 41%, respectively.
In the second aggregation level for CoD (22 subgroups), costs
for intentional injuries (self-harm and interpersonal violence)
were highest (43% of the total), followed by transport injuries (9%)
and neonatal disorders (8%). Mental and behavioral disorders and
neglected tropical diseases and malaria were the groups with a
lower lost (o1% of the total). Musculoskeletal disorders and non–
Global Burden of Disease groups do not include avoidable events
(Figs. 3 and 4). In men, 51% of the AM costs correspond to
intentional injuries, followed by transport injuries (10%), whereas
in women the main causes of AM costs were intentional injuries
(16%), neonatal disorders (14%), neoplasms (11%), and diarrhea,
lower respiratory tract infections, meningitis, and other common
infection diseases (10%).In the analysis with the maximum disaggregation (236 CoD),
among the four highest cost causes, three were injuries: assault
by ﬁrearm (US $26.5 billion to US $49.4 billion, 33% of total costs),
assault by sharp object (US $3.8 billion to US $7.2 billion, 5%), and
self-harm (US $2.8 billion to US $5.3 billion, 4%). Preterm birth
complications was the third costly CoD (US $3.2 billion to US $5.9
billion, 4%). In the ﬁfth position appeared other lower respiratory
tract infections (US $2.8 billion to US $5.2 billion, 3%), followed by
ischemic heart disease (US $2.6 billion to US $4.8 billion, 3%),
motorized vehicle with two wheels (US $2.3 billion to US $4.4
billion, 3%), injuries of undetermined intention (US $2.2 billion to
US $4.2 billion, 3%), HIV disease resulting in other speciﬁed or
unspeciﬁed diseases (US $2.2 billion to US $4.1 billion, 3%), and
pedestrian injury by road vehicle (US $1.8 billion to US $3.3
billion, 2%).
In men, disaggregating the top 10 causes showed that 49% of
the costs were concentrated in assault by ﬁrearm (40%), assault
by sharp object (6%), and self-harm (3%). In women, 30% of the
costs were due to assault by ﬁrearm (9%), preterm birth compli-
cations (7%), other lower respiratory tract infections (6%), con-
genital heart anomalies (4%), and self-harm (4%). In the later
population group, two neoplasms—cervical and breast cancers,
each one with 3% of the total costs—were also present.
Non GBD: Non global burden disease cause 
Fig. 4 – Avoidable mortality costs in the worst-case scenario per 22 GBD group causes: Colombia (1998–2011). HIV, HIV/AIDS;
TB, Tuberculosis; Dia, Diarrhea; LRI, Lower respiratory infections; Oth, other common infectious diseases; NTD, Neglected
tropical diseases; Maternal, Maternal disorders; Neonatal, Neonatal disorders; Ntr Def, Nutritional deﬁciencies; CVD, Cardi-
ovascular and circulatory diseases; Chr Resp, Chronic respiratory diseases; Neuro, Neurological disorders; Mental, Mental and
behavioral disorders; Diab, Diabetes; Urog, urogenital; Hem, blood; MSK, Musculosketeal disorders; NCD, Other non-commu-
nicable diseases; Tran Inj, Transport injuries; Unint Inj, Unintentional injuries other than transport injuries; Intent Inj, Self-
harm and interpersonal violence; disaster, forces of nature; Undet int Inj, Injuries with undetermined intent; GBD, global
burden disease.
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US $118.9 billion in the best-case and worst-case scenarios,
respectively, using a discount rate of 5% and US $124.9 billion
and US $233.2 billion in the best-case and worst-case scenarios,
respectively, using no discount rate.Discussion
This study describes the economic impact of AM in Colombia and
estimates the extent of potential losses due to avoidable death.
There are several analyses of mortality costs on the subnational
level and for some events [9,19,20,33]; also, there are interna-
tional studies, but none reports results of AM for Colombia [14].
The present study is the ﬁrst national analysis of the costs of AM
for Colombia. During the period 1998 to 2011, the total produc-
tivity losses in the labor market due to AM were approximately
between US $80.5 billion and US $150.4 billion (at a 3% discount
rate). Annually, the loss was between US $5.8 billion and US $10.7
billion, equivalent to between 1.6% and 3.0% of the GDP. There is
a decreasing trend in the costs of AM since 2003. Differences also
exist among departments; for example, Caquetá, Guaviare,
Arauca, Meta, and Valle del Cauca had an average cost of more
than US $185,000 per 1000 in the best-case scenario.
The costs of AM in Colombia were mainly for events from the
injuries group (US $49.0 billion to US $91.5 billion), whereas
communicable, maternal, neonatal, and nutritional disorders and
noncommunicable diseases report similar costs (between US $15billion and US $30 billion each). During the period 2008 to 2011,
costs of noncommunicable diseases started to be more relevant
than costs of communicable, maternal, neonatal, and nutritional
disorders. This could be explained largely by four behavioral risk
factors associated with economic transition, rapid urbanization,
and lifestyles: tobacco consumption, unhealthy diets, physical
inactivity, and harmful alcohol consumption, especially in low-
and middle-income countries such as Colombia [34].
The annual impact of injuries in the Colombian population
corresponds to between 1.0% and 1.8% of the GDP. Other studies
have also shown the importance of injuries in the total mortality
costs [33]. In our analysis, 33% of the total costs were due to
assault by ﬁrearm. Costs in men were 3.4 times higher than in
women, due to more and early avoidable deaths occurring in
men. In this group, the ﬁrst four CoD were assault by ﬁrearm,
assault by sharp object, self-harm, and injuries by motorized
vehicle with two wheels. Homicide is a complex phenomenon in
which behavioral, structural, and cultural elements converge,
which does not allow explaining so easily the reasons why it
occurs [35]. In women, the ﬁrst CoD corresponds to assault by
ﬁrearm, followed by preterm birth complication, lower respira-
tory tract infections, and congenital heart abnormalities, but it
should also be noted that cervical and breast cancers were among
the top 10 costly CoD in women.
Other analyses in Colombia have shown that in Cartagena
city during the period 2000 to 2005, the total cost of avoidable
deaths, according to the Taucher [36] list, was estimated to be
US$ 310,3 million to US$ 6,323.3 billion in 2005, adjusting for
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Cartagena, during the period 1995 to 2000, the cost was esti-
mated to be US $15.9 million in 2000 [9]. Other cost analyses of
total mortality have been done for two Colombian regions. In
the Colombian Amazonia, the total mortality cost for the period
2004 to 2008 was estimated to be COP 2380 billion in 2008 [20],
while for the same period in the Caribbean region, the cost was
estimated to be US $8.5 billion in 2008 [19]. The cost analysis of
premature mortality has also been carried out for other coun-
tries [12,14,16,18,37]. Thus, this study is a contribution to the
economic impact studies of AM.
In this analysis, we obtained a huge difference in costs by sex
using the human capital approach, with higher costs in men,
considering the less productive period and early retirement age
in women, according to the Colombian labor market. Given this,
we conducted an analysis considering the same age in men and
women (up to 62 years) and found that the total costs in women
changed from US $18.0 billion to US $ 21.8 billion in the best-case
scenario and US $33.6 billion to US $40.6 billion in the worst-case
scenario, providing evidence that higher costs in men are not
only due to retirement age but also because men die more and
younger than women.
This analysis has limitations. First, there is a possibility of
misclassiﬁcation of avoidable deaths that required an in-depth
analysis. According to the classiﬁcation of the Colombian
National Health Observatory, an avoidable death corresponds to that
death that potentially should not occur in the presence of the
corrected intervention of the health system or the availability of
public policies in place. Second, the use of the human capital
approach for the economic evaluation tends to give more value to
loss in population during the working age. In fact, some authors
argue that this method generates an inferior limit to the real value of
a person’s life [38], but we need an additional approach that does not
consider human beings only as production instruments [39]. In this
sense, it will be a conservative analysis of the costs of AM in
Colombia. However, some authors argue that the human capital
approach could overestimate indirect costs because the production
loss due to premature death can be replaced by unemployed people
[40] and recommend the use of analyses targeted on friction costs or
another kind of model [10]. Our analysis considered neither unem-
ployment rates nor friction costs because their use implies evaluat-
ing differential costs among departments and sex, valuing less the
loss in departments with bigger problems in their labor market (with
higher unemployment rates). To produce a comparable estimation
among departments and sex, those adjustments were not included,
and the same annual wages for the entire population for low and
high limits were assumed. The third limitation was related to the
possible underreporting of mortality events documented in other
studies for Colombia [20]. This aspect could increase the costs
reported here in a differential way among departments and because
of this underreporting rates also vary among departments. The last
limitation is that AM analysis evaluates the ﬁnal outcome of the
problem (i.e., avoidable deaths correspond to avoidable diseases), but
it forgets conditions that are not lethal, events that also cause
economic costs to the society, and the AM costs exclude the treat-
ment costs during the disease before that condition causes death.Conclusions
The costs of AM in Colombia, considering only the productivity
loss, are very signiﬁcant, especially the cost due to injuries.
Interventions to reduce the occurrence of these events could avoid
the productivity loss, in addition to the reduction in treatment and
indirect costs before death. Although controversies over the
economical valuation of life are present, this approach of analysispresents potentially useful results in the prioritization of public
health interventions taking into account the exposed limitations.
The economic analysis in public health is an additional input in
the decision-making process, generally presenting a monetary
valuing of a health phenomena with many perspectives for the
interpretation. In this case, we based our analysis on the fact that
premature death interrupts the productive life because of a poten-
tially avoidable cause, where the human capital perspective can be
applicable, estimating the wages unearned, to the population level.
This analysis could be used in cost-beneﬁt analysis for the selection
of potential interventions on the basis of economic criteria.
Differential proﬁles between men and women require inter-
vention targeted at the most important problem in each group. In
men, injuries have more economical impact, whereas in women
the group of communicable, maternal, neonatal, and nutritional
disorders and noncommunicable diseases including cervical and
breast cancers are very important.
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